BIOLASE, INC Quarterly Common Stock, Shares Authorized from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Biolase, Inc quarterly Common Stock, Shares Authorized history and growth rate from Q4 2010 to Q3 2024.
  • Biolase, Inc Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 180M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 180M 0 0% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 180M 0 0% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 180M 0 0% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 180M 0 0% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 180M 0 0% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 180M 0 0% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 180M 0 0% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 180M 0 0% Dec 31, 2022 10-K 2024-03-21
Q3 2022 180M 0 0% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 180M 0 0% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 180M 0 0% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 180M 0 0% Dec 31, 2021 10-K 2023-03-28
Q3 2021 180M 0 0% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 180M 0 0% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 180M +140M +350% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 180M +140M +350% Dec 31, 2020 10-K 2022-03-17
Q3 2020 180M +180M Sep 30, 2020 10-Q 2020-11-13
Q2 2020 180M +180M Jun 30, 2020 10-Q 2020-08-14
Q1 2020 40M +40M Mar 31, 2020 10-Q 2020-05-08
Q4 2019 40M 0 0% Dec 31, 2019 10-K 2022-03-17
Q3 2019 40K* -40M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 40K* -40M Jun 30, 2019 10-Q 2019-08-09
Q1 2019 40K* -200M Mar 31, 2019 10-Q 2019-05-10
Q4 2018 40M 0 0% Dec 31, 2018 10-K 2020-03-30
Q3 2018 40M -160M -80% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 40M -160M -80% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 200M +100M +100% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 40M -60M -60% Dec 31, 2017 10-K 2019-03-08
Q3 2017 200M +100M +100% Sep 30, 2017 10-Q 2017-11-01
Q2 2017 200M +100M +100% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 100M 0 0% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 100M 0 0% Dec 31, 2016 10-K 2018-03-14
Q3 2016 100M 0 0% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 100M 0 0% Jun 30, 2016 10-Q 2016-08-01
Q1 2016 100M 0 0% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 100M 0 0% Dec 31, 2015 10-K 2017-03-10
Q3 2015 100M 0 0% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 100M +50M +100% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 100M +50M +100% Mar 31, 2015 10-Q 2015-05-01
Q4 2014 100M +50M +100% Dec 31, 2014 10-K 2016-03-11
Q3 2014 100M +50M +100% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 50M 0 0% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 50M 0 0% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 50M 0 0% Dec 31, 2013 10-K 2015-03-06
Q3 2013 50M 0 0% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 50M 0 0% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 50M 0 0% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 50M 0 0% Dec 31, 2012 10-K 2014-03-17
Q3 2012 50M 0 0% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 50M 0 0% Jun 30, 2012 10-Q/A 2012-09-06
Q1 2012 50M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 50M 0 0% Dec 31, 2011 10-K 2013-03-15
Q3 2011 50M Sep 30, 2011 10-Q 2011-11-10
Q2 2011 50M Jun 30, 2011 10-Q 2011-08-11
Q4 2010 50M Dec 31, 2010 10-K 2012-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.